Biocure Technology (XCNQ:CURE) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 31, 2025)

View and export this data going back to 2010. Start your Free Trial

What is Biocure Technology Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Biocure Technology's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Biocure Technology's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Biocure Technology's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biocure Technology's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocure Technology's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Biocure Technology's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Biocure Technology (XCNQ:CURE) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Biocure Technology Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Biocure Technology's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocure Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocure Technology Inc (XCNQ:CURE) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

BICTF:USA 1WH0:Germany

Address

1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9

Website

https://www.biocuretech.com

Biocure Technology Inc is a biopharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It is Developing Biosimilars and CAR-T Cell pharmaceuticals. Its products are CAR-T Cell Therapy, Interferon Beta, Ranibizumab, and PEG-Filgrastim.

Executives

Konstantin Lichtenwald

Director, Senior Officer